Tag: legalized marijuana

Ohio Senators Approve Bill To Scale Back Voter-Approved Marijuana Legalization Law By Reducing Home Grow And Adding New Penalties

An Ohio Senate committee has approved a bill to make significant changes to the state’s voter-approved marijuana law—by halving the number of plants adults could grow, adding certain criminal penalties and removing select social equity provisions, among other revisions.

On Wednesday, the Senate General Government Committee passed the legislation from Sen. Steve Huffman (R) in a 5-2 vote, sending it to the Rules and Reference Committee to prepare it for a full Senate vote that come come as early as Wednesday afternoon.

This comes about a week after the panel held a hearing on the proposal, taking testimony and adopting a substitute version. On Wednesday, the panel adopted an additional substitute that would clarify that THC limits per package don’t apply to products intended for combustion, prevent people with felony convictions from obtaining a marijuana license and restore the ability of level two cultivators to expand their operations to 15,000 square feet.

In its initial form, the bill would have raised the state’s excise tax on marijuana products from 10 percent to 15 percent and also changed how taxes are redistributed to local governments. But those tax provisions were removed at the previous hearing in light of separate plans to adjust the tax rate in broader budget legislation.

Democratic members of the committee offered a series of amendments, several of which sought to dial back some of the proposed changes to the voter-approved law. All were defeated by the panel’s Republican majority, however.

For example, the substitute approved in committee would lower the maximum household plant limit for home cultivation from 12 to six. An amendment was offered to “compromise” by raising that to nine.

Huffman made the motion to table that amendment, saying that “this bill is all about being reasonable and appropriate,” and the legislation “initially started with two plants, and we compromised up to six and I believe that continuing as six is reasonable and appropriate.”

Under current law as approved by voters in 2023, adults can grow up to 12 cannabis plants at home.

Reform advocates oppose the legislation because, in addition to halving the home cultivation limit, they say it would recriminalize the sharing of cannabis between adults, smoking or vaping in someone’s own back yard and transporting unopened edibles in a vehicle. It also would eliminate non-discrimination protections to ensure cannabis consumers aren’t denied child custody, access to medical care and public benefits.

Keep reading

Ohio GOP Lawmakers Introduce Bill To Raise Marijuana Tax, Restrict Home Grow And Eliminate Social Equity Funding

Ohio Republican lawmakers are reviving an effort to significantly alter the state’s voter-approved marijuana legalization law—in part by raising the tax on cannabis products, halving the number of plants adults could grow and eliminating certain social equity provisions.

While GOP leadership has generally pledged that they will not seek to repeal the marijuana law altogether, a newly filed bill from Sen. Steve Huffman (R)—which the Senate president signaled he supports—would make major changes that substantially depart from the provisions of the initiative that voters strongly approved in 2023.

Among the proposed revisions, the bill would increase the excise tax on marijuana from 10 percent to 15 percent. And rather than have revenue allocated to specific areas supporting social equity and jobs programs, local governments that permit marijuana businesses, education and substance misuse initiatives and more, all revenue would instead go to the state general fund.

Senate President Rob McColley (R) told The Columbus Dispatch that legislators intend to discuss possible disbursements of that revenue this session, but he said he’s aligned with the bill sponsor on the idea of increasing the tax rate for cannabis.

“There’s an awful lot of societal costs that are going to have to be borne by the legalization of marijuana,” he said.

Under Huffman’s bill, adults would only be able to grow up to six plants, rather than 12, for personal use. It would also decrease the THC content cap from 90 percent to 70 percent.

Further, the proposal would limit the number of dispensaries to 350, while requiring all licensed retailers to serve both adult-use consumers and medical cannabis patients. The state Division of Cannabis Control (DCC) would also no longer be required to establish rules allowing for marijuana deliveries and online purchases.

GOP lawmakers considered a variety of potential amendments to the marijuana law in the weeks after voters passed the ballot initiative, and this latest attempt is likely to see similar pushback.

Sen. Bill DeMora (D) said during a committee hearing on Wednesday that the proposal effectively amounts to legislators telling voters: “Screw you, you don’t know what you’re talking about. You passed it with an overwhelming majority in the state, but we know better than they did what they were voting on.”

Huffman, the bill sponsor, said the legislation is not meant to “do away with the ballot initiative.”

“It’s to work around the edges to make it better,” he said.

Keep reading

Analysis: Steep Declines in Teen Marijuana Use in States With Regulated Cannabis Markets

Marijuana use by teens has fallen sharply in the majority of states that have legalized the adult-use market, according to an analysis of state and federal survey data by the Marijuana Policy Project.

MPP’s analysis acknowledges steady declines in self-reported marijuana use by young people in 19 of 21 states for which data is available. Federally funded survey data shows similar nationwide declines in teen marijuana use over the past decade.

“Over a decade into state-level cannabis legalization, the data is unequivocal: Legalization does not increase youth cannabis use. In fact, evidence suggests the opposite,” said Karen O’Keefe, Director of State Policies at the Marijuana Policy Project. “By transitioning cannabis sales from the illicit market to a regulated system with age-restricted access, we’ve seen a decrease in youth cannabis use.”

Last month, national data provided by the University of Michigan’s Monitoring the Future study reported that marijuana use by teens fell to historic lows in 2024. Specifically, it determined that the percentage of 8th graders, 10th graders, and 12 graders who reported having ever consumed cannabis declined 32 percent, 37 percent, and 23 percent since 2014.

Keep reading

In 2024, 11 states surpassed $1 billion in legal marijuana sales.

Collectively, these states accounted for a large majority of the $23.2 billion sold across the 21 states with operational recreational markets.

California led the pack with $4.2 billion in sales, followed by Michigan, which brought in $3.1 billion. Illinois ($1.8 billion) and Massachusetts ($1.75 billion) also contributed significantly to the billion-dollar club. Other high-performing states included Colorado ($1.35 billion), Missouri ($1.36 billion), and Arizona ($1.21 billion).

Maryland, Washington, and New Jersey each reported $1.1 billion in revenue. Meanwhile, New York, in its first full year of sales, reached $1 billion, demonstrating its potential to eventually become one of the largest marijuana markets in the nation.

Keep reading

NY coffers hit new high from marijuana tax receipts: ‘It’s extraordinary’

New York’s coffers are starting to get a financial high from marijuana sales after a slow start.

The Empire State is expected to generate $161.8 million in tax revenues from its legal weed business for the fiscal year ending March 31 — or four times what it raked in last year.

Gov. Kathy Hochul’s budget released last week also projects generating $248 million in revenue from the state-licensed cannabis industry for the next fiscal year running from April 1 to March 31, 2026.

That’s a lot of green — up from $43.3 million raised in 2022-2023 amid a fitful rollout of the program.

State budget officials predict the revenues will then grow to $339 million in FY 2027, $363 million in 2028 and $374 million by 2029, based on expansion of the legal market.

Keep reading

Trump’s New DEA Head Says Marijuana Is A ‘Gateway Drug’ That Causes Psychosis And Other Mental Health Problems

The official named to run the Drug Enforcement Administration (DEA) as acting administrator subscribes to the “gateway drug” theory for marijuana and believes most people living in states that have legalized cannabis will continue to obtain it from illicit sources such as cartels due to high taxes in regulated markets.

As the Trump administration takes shape, marijuana reform advocates and stakeholders are getting to learn more about the newly announced acting administrator, Derek Maltz. And so far, a review of his record has done little to assure the cannabis community that he would serve as an ally in the push for reform at DEA.

Maltz, who retired from the agency in 2014 after 28 years of service, has made a series of sensational comments about cannabis—at one point linking marijuana use to school shootings, for example. But he evidently also holds a more common prohibitionist position: He thinks cannabis is a gateway to harder drugs, despite numerous studies contradicting that theory.

“Marijuana is not the marijuana from the 70s or the 80s or the 90s. This is higher, pure-THC marijuana,” he said during an interview with NTD at a Turning Point USA event last year. “I’ve talked to doctors about this. It’s actually causing psychosis, schizophrenia, depression, anxiety—so it’s really a gateway drug for these kids that don’t know any better.”

Keep reading

With more Americans able to access legalized marijuana, fewer are picking up prescriptions for anti-anxiety medications – new research

In states where both medical and recreational marijuana are legal, fewer patients are filling prescriptions for medications used to treat anxiety. That is the key finding of my recent study, published in the journal JAMA Network Open.

I am an applied policy researcher who studies the economics of risky behaviors and substance use within the United States. My collaborators and I wanted to understand how medical and recreational marijuana laws and marijuana dispensary openings have affected the rate at which patients fill prescriptions for anti-anxiety medications among people who have private medical insurance.

These include:

  • Benzodiazepines, which work by increasing the level of gamma-aminobutyric acid, or GABA, a neurotransmitter that elicits a calming effect by reducing activity in the nervous system. This category includes the depressants Valium, Xanax and Ativan, among others.
  • Antipsychotics, a class of drug that addresses psychosis symptoms in a variety of ways.
  • Antidepressants, which relieve symptoms of depression by affecting neurotransmitters such as serotonin, norepinephrine and dopamine. The most well-known example of these is selective serotonin re-uptake inhibitors, or SSRIs.

We also included barbiturates, which are sedatives, and sleep medications – sometimes called “Z-drugs” – both of which are used to treat insomnia. In contrast to the other three categories, we did not estimate any policy impacts for either of these types of drugs.

We find consistent evidence that increased marijuana access is associated with reductions in benzodiazepine prescription fills. “Fills” refer to the number of prescriptions being picked up by patients, rather than the number of prescriptions doctors write. This is based on calculating the rate of individual patients who filled a prescription in a state, the average days of supply per prescription fill, and average prescription fills per patient.

Notably, we found that not all state policies led to similar changes in prescription fill patterns.

Keep reading

Fatal Traffic Crashes Linked To Marijuana Fell By 30% In Ohio Last Year As Legalization Took Effect, Contrary To Opponents’ Fears

As marijuana legalization took effect in Ohio over the last year, the number of fatal traffic crashes in linked to cannabis fell by 30 percent—contrary to warnings from opponents of the policy change who feared it would lead to more deadly car accidents involving stoned drivers. That’s according to new preliminary data from the Ohio State Highway Patrol, which found that proportion of impaired drivers suspected to be under the influence of marijuana also declined compared to 2023.

State voters approved marijuana legalization in November 2023, with use and possession becoming legal the following month. Adult-use cannabis sales, meanwhile, began last August.

State voters approved marijuana legalization in November 2023, with use and possession becoming legal the following month. Adult-use cannabis sales, meanwhile, began last August.

All told, there were 1,067 fatal traffic crashes in Ohio during 2024—the lowest number in at least five years, and down 7 percent from the 1,150 fatal crashes in 2023.

Of those, about 20 percent (215 crashes) were linked to cannabis last year—also the lowest number in years, and down from 27 percent (306 crashes) in 2023.

Impaired driving—referred to in Ohio as operating a vehicle under the influence, or OVI—also decreased from 2023 to 2024, with 644 fewer arrests last year compared to a year earlier. There were 83 fewer cannabis-related OVI arrests in 2024 compared to 2023.

In 2023, authorities logged 15,276 OVI arrests, about 10 percent (1,454) of which were related to marijuana. In 2024, 14,632 arrests took place—a decrease of about 4 percent. Of those, 1,371 were suspected to be linked to cannabis—a drop of approximately 6 percent.

Overall, 242 people died in Ohio last year in crashes believed to involve marijuana use. That’s 28 percent fewer deaths than the 335 logged in 2023. It’s also the lowest number of fatal traffic accidents involving cannabis since at least 2020.

The total number of crashes in general linked to marijuana in 2024—1,171—was also the lowest number since at least 2020 and marked a 12 percent decline since 2023.

Keep reading

New York Democrat Files Bills To Restrict THC Potency In Marijuana And Ban Consumption Within 30 Feet Of Children

A New York Democrat has introduced a pair of bills that would put new restrictions on marijuana in the state. One measure would limit the THC potency of cannabis products, while the other would prohibit cannabis consumption within 30 feet of where any child lives.

Both bills, A977 and A1007, were filed on Wednesday by Assemblymember Phil Steck. The potency proposal would limit marijuana flower to no more than 15 percent delta-9 THC, while all other cannabis products—including concentrates and hemp-derived products—would be capped at 25 percent delta-9 THC.

Growing, processing or distributing products exceeding those limits would be a Class B misdemeanor, punishable by up to 90 days in jail and a $500 fine.

The consumption measure, meanwhile, would outlaw smoking or vaping cannabis “within thirty feet of a child or within thirty feet of any location in which children reside or attend for any recreational or educational purpose.”

The restriction would include “areas separated by walls, closed door or floors within a building,” meaning the change could theoretically limit cannabis consumption even within users’ private residences if their neighbors have kids.

In addition to that provision, the consumption bill would also step up penalties for second and subsequent offenses around unlawful marijuana use, such as consuming near schools or using in areas where smoking or vaping is otherwise prohibited. Currently those activities are civil violations that carry a fine of up to $25 or community service. Under Steck’s bill, that would still be true for the first offense, but subsequent offenses would be charged as Class B misdemeanors.

A legislative memo in support of tighter consumption restrictions says that research has “shown that second-hand smoke from vaping and smoking cannabis are proven to be harmful to the health of adults and children.”

“Most adults have to ability to remove themselves from the area, children may not have the same ability,” the memo says. “This bill requires adults maintain a safe distance from children when smoking or vaping cannabis.”

As for Steck’s proposed THC limit, the memo in support of that proposal says that “the most egregious omission in legalizing adult-use cannabis in New York State is the absence of any cap on its potency.”

“Most people can use cannabis safely,” it says, but with increased availability of higher THC concentrations, there have been more adverse drug reactions.”

The memo also says that in particular, “edibles are trouble,” citing a study out of Colorado that found that edibles accounted for less than 1 percent of statewide cannabis sales but were responsible for 11 percent of emergency room visits.

“With an eye towards public health and safety,” it adds, “this legislation imposes a 15 percent cap on any cannabis flower, and a 25 percent cap on the concentration of the active ingredient delta-9 tetrahydrocannibinol in all manufactured cannabis products in the state.”

Notably, the bill would not adjust the total allowable THC limits in state-legal cannabis edibles, and the percentage-based limits would likely do little to rein in potency of the products. Even at the proposed 25 percent THC limit, a gummy weighing just 2 grams could contain up to half a gram of THC—a massive dose for most consumers.

The advocacy group NORML quickly came out against the new potency bill, A977, calling its proposed limits “arbitrary” in an email to supporters on Thursday.

Keep reading

Youth Marijuana Use Hasn’t Increased In States That Legalize, And Most Actually See Significant Declines, Analysis Of Government Data Shows

Youth marijuana use declined in 19 out of 21 states that legalized adult-use marijuana—with teen cannabis consumption down an average of 35 percent in the first states to legalize a decade ago—according to government data compiled by a leading advocacy group.

The Marijuana Policy Project (MPP) report analyzed multiple studies on how state cannabis laws influence youth use trends, including several led by federal agencies. The group found that the “data is unequivocal,” Karen O’Keefe, director of state policies at MPP, said.

“Legalization does not increase youth cannabis use,” she said, pushing back on an argument often made by opponents of the reform. “In fact, evidence suggests the opposite. By transitioning cannabis sales from the illicit market to a regulated system with age-restricted access, we’ve seen a decrease in youth cannabis use.”

The report cited data from a series of national and state-level youth surveys, including the annual Monitoring the Future (MTF) Survey, which is supported by the National Institute on Drug Abuse (NIDA).

The latest version of the MTF released last month found that cannabis use among 8th, 10th and 12 graders is now lower than before the first states started enacting adult-use legalization laws in 2012. There was also a significant drop in perceptions by youth that cannabis is easy to access in 2024 despite the widening adult-use marketplace.

Another recent survey included in MPP’s analysis came from the Centers for Disease Control and Prevention (CDC), which also showed a decline in the proportion of high-school students reporting past-month marijuana use over the past decade, as dozens of states moved to legalize cannabis.

At the state level, the cannabis group looked at research such as the Washington State Healthy Youth Survey that was released last April.

Keep reading